Better Cognitive Outcomes Tied to Vigorous Exercise in Hypertensive Adults SPRINT MIND analysis looks at 7,600 older adults at high risk of cognitive decline Jun 06, 2024
MDMA's Cardiac Safety Concerns; Entresto Generics; Heart Disease 'Older Than Moses' Recent developments of interest in cardiovascular medicine Jun 04, 2024
Hypertension After Kidney Donation; Statins in Old and Very Old People Also in TTHealthWatch: fluoride's effect on pregnancy outcomes Jun 01, 2024 podcast
Young-Onset Dementia Tied to Preeclampsia Study of 2 million women in France identifies new association May 30, 2024
Fish Oil Benefits or Harms; Statins at Age 85+; Doc's Hunger Strike for Bed Space Recent developments of interest in cardiovascular medicine May 28, 2024
New PAD Guidelines; AHA on Postpartum Care; Exercise Didn't Stop CAC Progression Recent developments of interest in cardiovascular medicine May 21, 2024
PROTECT Drugs Tied to Slower eGFR Decline vs Standard Care in IgA Nephropathy Slower kidney function decline observed with sparsentan and irbesartan May 20, 2024
Draw Between Two Diuretics for Renal Prevention in Hypertension But researcher questions if patients were underdosed May 16, 2024
Balloon Pump Warning; Afib Rhythm Control vs Dementia; Doc's Sex Crime Charges Recent developments of interest in cardiovascular medicine May 14, 2024
SGLT2i for Mitral Regurgitation; Mining Angiograms With AI; Melatonin and CVD Risk? Recent developments of interest in cardiovascular medicine May 07, 2024
Kids With Hypertension May Have Twice the Risk of Cardiac Events "Hypertension in children is not a benign condition," researcher says May 06, 2024
Devices Flop for Severe PAD; CPR on LVAD Patients; Cancer Drugs for Heart Disease? Recent developments of interest in cardiovascular medicine Apr 30, 2024
More Cases of Asthma, COPD, Hypertension After Military Burn Pit Exposure Ask veterans with symptoms if they were deployed to bases with open burn pits, says expert Apr 25, 2024
High BMI and Longevity; Infective Endocarditis in Young Whites; Damar Hamlin Update Recent developments of interest in cardiovascular medicine Apr 23, 2024
FDA Advisors' COIs; Ongoing Ukraine Heart Transplants; N.J. Cardiologist's $2M Fraud Recent developments of interest in cardiovascular medicine Apr 16, 2024
Multidisciplinary Team Intervention Flops for Improving CKD Outcomes Intervention "did not overcome barriers" to PCP, patient behavior changes, editorialists say Apr 15, 2024
Novel Biannual Antihypertensive Shows Potential for Combination Therapy Drug might be most effective with a diuretic, according to suggestive data from a phase II trial Apr 09, 2024
Radial Cath Kits Recalled; siRNAs for Lipid Lowering; Smartphone HF Detection Recent developments of interest in cardiovascular medicine Apr 09, 2024
Oral Appliance for Sleep Apnea Noninferior to CPAP for Reducing Arterial BP For patients with hypertension, oral device may be an option for those who cannot tolerate CPAP Apr 09, 2024
Primary Care Strategy Fails to Reduce Kidney-Dysfunction Triad Hospitalizations Secondary outcomes also showed no significant differences Apr 03, 2024
FDA Approves TriClip; Fortified Eggs vs Cholesterol; Impella Maker Chided Recent developments of interest in cardiovascular medicine Apr 02, 2024
Sotatercept's FDA Approval a New Chapter for Pulmonary Arterial Hypertension Biologic should arrive on pharmacy shelves before May Mar 27, 2024
Red Meat-CVD Link Questioned; Drone AEDs to Bystanders; OCT-FFR in One Step? Recent developments of interest in cardiovascular medicine Mar 26, 2024
Fixed-Dose Macitentan/Tadalafil Combo Gets FDA Approval for PAH Opsynvi puts two drugs commonly prescribed for pulmonary arterial hypertension into one tablet Mar 25, 2024
Novel Oral Antihypertensive Gets FDA's Blessing Aprocitentan becomes the first endothelin receptor antagonist for BP lowering Mar 20, 2024
Structural Heart Metrics Debut; Amenorrhea-CVD Link; Once-a-Day Antianginal? Recent developments of interest in cardiovascular medicine Mar 18, 2024
EHR Alerts Trigger Primary Care Clinics to Improve Hypertension Care in CKD Greater reduction in systolic BP over usual care in randomized trial Mar 15, 2024
LVAD Monitoring App Recall; ADHD Drug & CVD Risk; Value of ATTR Treatments? Recent developments of interest in cardiovascular medicine Mar 12, 2024
Deaths Due to Alcohol Use; Steps for the Sedentary Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
Cardiometabolic Disorders Tend to Accompany a 'Lazy Eye' Persistent amblyopia associated with myocardial infarction and death Mar 08, 2024
Interventions Can Reduce CVD Risk Factors in HIV Patients, Studies Show Lowering blood pressure, cholesterol prove feasible in randomized trials Mar 07, 2024
First DCB Approved; DAPT Bleeds With Low LDL-C; Pre-CABG Cardiac Rehab Recent developments of interest in cardiovascular medicine Mar 05, 2024
SNAP Benefits and BP Meds; Post-PCI Anticoagulation Flop; CPAP's Potential Harm Recent developments of interest in cardiovascular medicine Feb 27, 2024
TAVR Pioneer Dies; Allograft Rejection Criteria Need Work; Overeating Protein & CVD Recent developments of interest in cardiovascular medicine Feb 20, 2024
Primordial Prevention Can Protect Black Women's Cardiovascular Health Let's block the risk factors before they start Feb 19, 2024
Hypertension, Diabetes in Pregnancy Affects Offspring's Heart Health in Adolescence Hypertensive disorders of pregnancy and gestational diabetes are both on the rise Feb 16, 2024
RNA Silencer Zilebesiran: Infrequent Injections Bring Down BP Sustained BP reductions seen in early trial whether patients got one or two doses in 6 months Feb 16, 2024
Salt Subs in Normal BP; Stroke Thrombectomy Without $$; Walmart's CVD Blood Test Recent developments of interest in cardiovascular medicine Feb 13, 2024
Bariatric Surgery & BP Control; PFA Vasospasm Aftermath; Texas Cardiologist Arrested Recent developments of interest in cardiovascular medicine Feb 06, 2024
Tirzepatide's Association With BP Reduction Reinforced With ABPM Data Combination GLP-1/GIP receptor agonist is currently approved for T2D and weight loss Feb 05, 2024